Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henrik Vestergaard

Showing results (11-20 of 133) with videos related to

Pageof 14
Sort By:
European Journal of Internal Medicine|January 22, 2008
Higher prevalence of risk factors for type 2 diabetes mellitus and subsequent higher incidence in menThomas Almdal, Henrik Scharling, Jan Skov Jensen, et al.
Cardiovascular Diabetology|December 15, 2010
Increased levels of the calcification marker matrix Gla Protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart diseaseStine B Thomsen, Camilla N Rathcke, Bo Zerahn, et al.
Pharmacogenetics and Genomics|July 17, 2015
Pharmacogenetics and individual responses to treatment of hyperglycemia in type 2 diabetesLine Engelbrechtsen, Ehm Andersson, Soeren Roepstorff, et al.
Plos One|September 1, 2012
Variations of CHI3L1, levels of the encoded glycoprotein YKL-40 and prediction of fatal and non-fatal ischemic strokeCamilla Noelle Rathcke, Stine Brinkloev Thomsen, Allan Linneberg, et al.
World Journal of Surgery|December 3, 2003
Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977-1993 in DenmarkChristina G Øgard, Gerda Engholm, Thomas P Almdal, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 7, 2012
Short-term teriparatide treatment does not affect NT-proBNP, a marker of cardiac diseaseMaria Ellegaard, Peter Schwarz, Caroline R Hansen, et al.
Clinical Endocrinology|May 12, 2007
N-terminal pro-B-type natriuretic peptide in patients with growth hormone disturbancesMikkel Andreassen, Jens Faber, Henrik Vestergaard, et al.
Diabetes Care|October 30, 2008
YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuriaCamilla Noelle Rathcke, Frederik Persson, Lise Tarnow, et al.
The Journal of Endocrinology|October 12, 2018
Fasting decreases plasma FGF21 in obese subjects and the expression of FGF21 receptors in adipose tissue in both lean and obese subjectsEva B Nygaard, Cathrine Ørskov, Thomas Almdal, et al.
European Journal of Epidemiology|March 7, 2006
Serum ionised calcium and cardiovascular disease in 45-years old men and women followed for 18 yearsChristina Gerlach Ogard, Janne Petersen, Torben Jørgensen, et al.
Pageof 14

Showing results (11-20 of 133) with videos related to

Sort By:
Pageof 14
European Journal of Internal Medicine|January 22, 2008
Higher prevalence of risk factors for type 2 diabetes mellitus and subsequent higher incidence in menThomas Almdal, Henrik Scharling, Jan Skov Jensen, et al.
Cardiovascular Diabetology|December 15, 2010
Increased levels of the calcification marker matrix Gla Protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart diseaseStine B Thomsen, Camilla N Rathcke, Bo Zerahn, et al.
Pharmacogenetics and Genomics|July 17, 2015
Pharmacogenetics and individual responses to treatment of hyperglycemia in type 2 diabetesLine Engelbrechtsen, Ehm Andersson, Soeren Roepstorff, et al.
Plos One|September 1, 2012
Variations of CHI3L1, levels of the encoded glycoprotein YKL-40 and prediction of fatal and non-fatal ischemic strokeCamilla Noelle Rathcke, Stine Brinkloev Thomsen, Allan Linneberg, et al.
World Journal of Surgery|December 3, 2003
Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977-1993 in DenmarkChristina G Øgard, Gerda Engholm, Thomas P Almdal, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 7, 2012
Short-term teriparatide treatment does not affect NT-proBNP, a marker of cardiac diseaseMaria Ellegaard, Peter Schwarz, Caroline R Hansen, et al.
Clinical Endocrinology|May 12, 2007
N-terminal pro-B-type natriuretic peptide in patients with growth hormone disturbancesMikkel Andreassen, Jens Faber, Henrik Vestergaard, et al.
Diabetes Care|October 30, 2008
YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuriaCamilla Noelle Rathcke, Frederik Persson, Lise Tarnow, et al.
The Journal of Endocrinology|October 12, 2018
Fasting decreases plasma FGF21 in obese subjects and the expression of FGF21 receptors in adipose tissue in both lean and obese subjectsEva B Nygaard, Cathrine Ørskov, Thomas Almdal, et al.
European Journal of Epidemiology|March 7, 2006
Serum ionised calcium and cardiovascular disease in 45-years old men and women followed for 18 yearsChristina Gerlach Ogard, Janne Petersen, Torben Jørgensen, et al.
Pageof 14